EA200801540A1 - Способ и композиция для лечения и диагностики синдрома усталых ног - Google Patents
Способ и композиция для лечения и диагностики синдрома усталых ногInfo
- Publication number
- EA200801540A1 EA200801540A1 EA200801540A EA200801540A EA200801540A1 EA 200801540 A1 EA200801540 A1 EA 200801540A1 EA 200801540 A EA200801540 A EA 200801540A EA 200801540 A EA200801540 A EA 200801540A EA 200801540 A1 EA200801540 A1 EA 200801540A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- agent
- pharmaceutical composition
- iron
- pharmaceutically acceptable
- receptor stimulating
- Prior art date
Links
- 208000011580 syndromic disease Diseases 0.000 title abstract 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 6
- 239000003795 chemical substances by application Substances 0.000 abstract 6
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 6
- 239000002269 analeptic agent Substances 0.000 abstract 3
- 229960003638 dopamine Drugs 0.000 abstract 3
- 230000003291 dopaminomimetic effect Effects 0.000 abstract 3
- 239000003937 drug carrier Substances 0.000 abstract 3
- 230000002708 enhancing effect Effects 0.000 abstract 3
- 229910052742 iron Inorganic materials 0.000 abstract 3
- 230000004060 metabolic process Effects 0.000 abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- FASDKYOPVNHBLU-ZETCQYMHSA-N pramipexole Chemical compound C1[C@@H](NCCC)CCC2=C1SC(N)=N2 FASDKYOPVNHBLU-ZETCQYMHSA-N 0.000 abstract 2
- 229960003089 pramipexole Drugs 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0502830 | 2005-12-20 | ||
| PCT/SE2006/050553 WO2007073325A1 (en) | 2005-12-20 | 2006-12-06 | Method and composition for treating and diagnosing restless legs syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA200801540A1 true EA200801540A1 (ru) | 2008-12-30 |
Family
ID=38188943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200801540A EA200801540A1 (ru) | 2005-12-20 | 2006-12-06 | Способ и композиция для лечения и диагностики синдрома усталых ног |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20090304816A1 (https=) |
| EP (1) | EP1973551A1 (https=) |
| JP (1) | JP2009520023A (https=) |
| KR (1) | KR20080078075A (https=) |
| CN (1) | CN101336109A (https=) |
| AU (1) | AU2006327254A1 (https=) |
| CA (1) | CA2634140A1 (https=) |
| EA (1) | EA200801540A1 (https=) |
| IL (1) | IL192325A0 (https=) |
| WO (1) | WO2007073325A1 (https=) |
| ZA (1) | ZA200805358B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2646250A1 (en) | 2006-04-03 | 2007-10-18 | Teva Pharmaceutical Industries Ltd. | Use of rasagiline for the treatment of restless legs syndrome |
| US10617694B2 (en) * | 2016-05-11 | 2020-04-14 | Jan Hedner | Sultiame for the treatment of sleep apnea |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US6960571B2 (en) * | 2003-03-14 | 2005-11-01 | Luitpold Pharmaceuticals, Inc. | Methods and compositions for administration of iron for the treatment of restless leg syndrome |
| EP1635804B1 (fr) * | 2003-05-30 | 2016-09-21 | NLS-1 Pharma AG | Utilisation du fer pour le traitement du trouble du deficit de attention/hyper-activite chez les enfants |
| GB0319874D0 (en) * | 2003-08-22 | 2003-09-24 | Glaxo Group Ltd | Novel formulation |
| DE602004031134D1 (de) * | 2003-08-29 | 2011-03-03 | Transform Pharmaceuticals Inc | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa |
-
2006
- 2006-12-06 EA EA200801540A patent/EA200801540A1/ru unknown
- 2006-12-06 EP EP06824619A patent/EP1973551A1/en not_active Withdrawn
- 2006-12-06 AU AU2006327254A patent/AU2006327254A1/en not_active Abandoned
- 2006-12-06 US US12/158,172 patent/US20090304816A1/en not_active Abandoned
- 2006-12-06 WO PCT/SE2006/050553 patent/WO2007073325A1/en not_active Ceased
- 2006-12-06 KR KR1020087017787A patent/KR20080078075A/ko not_active Withdrawn
- 2006-12-06 JP JP2008547181A patent/JP2009520023A/ja active Pending
- 2006-12-06 CN CNA2006800517948A patent/CN101336109A/zh active Pending
- 2006-12-06 CA CA002634140A patent/CA2634140A1/en not_active Abandoned
-
2008
- 2008-06-19 IL IL192325A patent/IL192325A0/en unknown
- 2008-06-19 ZA ZA200805358A patent/ZA200805358B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101336109A (zh) | 2008-12-31 |
| IL192325A0 (en) | 2009-02-11 |
| US20090304816A1 (en) | 2009-12-10 |
| AU2006327254A1 (en) | 2007-06-28 |
| CA2634140A1 (en) | 2007-06-28 |
| ZA200805358B (en) | 2009-04-29 |
| JP2009520023A (ja) | 2009-05-21 |
| KR20080078075A (ko) | 2008-08-26 |
| EP1973551A1 (en) | 2008-10-01 |
| WO2007073325A1 (en) | 2007-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20062504L (no) | Sammensetninger og doseringsformer for forbedret absorpsjon | |
| CZ309247B6 (cs) | 40-O-(2-hydroxyethyl)rapamycin pro použití jako jediná účinná látka při léčení solidního nádoru | |
| DE60332629D1 (de) | Phenyl-(4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yi)aminderivate | |
| NO993520D0 (no) | Doseringsformer og fremgangsmåte for å bedre erektil dysfunksjon | |
| CY1115289T1 (el) | Μεθοδοι αγωγης εναντι ασθενειας που σχετιζεται με φλεγμονη | |
| ATE391708T1 (de) | Verbindungen und gemische zur verabreichung eines aktiven agens | |
| TW200716157A (en) | Pharmaceutical formulations and methods of treatment using the same | |
| WO2005107726A3 (en) | Method for the treatment of back pain | |
| AR027548A1 (es) | Derivados de amino pirazol utiles para el tratamiento de la obesidad y otros desordenes | |
| GB0222514D0 (en) | Organic compounds | |
| MXPA05008838A (es) | Formulaciones de absorcion acelerada del agonista selectivo de la 5-ht. | |
| NO20045240L (no) | Transepikutan administrasjonsform for a behandle restless legs syndromet | |
| NO20051414L (no) | Fremgangsmate for fremstilling av torrpulverinhaleringssammensetninger | |
| ATE357928T1 (de) | Pharmazeutische zusammensetzung für thrombinpeptidderivaten | |
| IS6558A (is) | Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni | |
| MY144897A (en) | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists | |
| GB2446341A (en) | Method and system for transdermal drug delivery | |
| EP1379508A4 (en) | N- (ARYL) -2-ARYLETHESULFONAMIDES AND THEIR THERAPEUTIC APPLICATIONS | |
| MXPA04011835A (es) | Tratamiento de combinacion para la depresion y ansiedad. | |
| CO5190664A1 (es) | Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2 | |
| EA200501166A1 (ru) | Составы и способы лечения тромбоцитемии | |
| EP1503748A4 (en) | DRUGS TO REDUCE TAXAN-INDUCED NEUROTOXICITY | |
| MXPA01008993A (es) | Tratamiento de combinacion para depresion y ansiedad. | |
| EA200801540A1 (ru) | Способ и композиция для лечения и диагностики синдрома усталых ног | |
| ATE431147T1 (de) | Mittel zur behandlung des integrationsdysfunktionssyndroms |